Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07342452 · ClinicalTrials.gov registry record · Phase 4
Randomized Trial of Combination Treatment With Sofwave and Sculptra
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Not yet
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT07342452: Clinical Trial Phase 4 study, sponsored by Massachusetts General Hospital.
NCT07342452 is a Phase 4 study that has not yet begun recruiting, run by Massachusetts General Hospital. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07342452, a Phase 4 study, has not yet begun recruiting, sponsored by Massachusetts General Hospital.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
Evaluation of treatment on the upper arm with Sculptra and Sofwave on the same day versus Sofwave followed by Sculptra 1 month later.
Interventions
- DEVICE Sofwave
- DRUG Sculptra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-04-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07342452
The ClinicalTrials.gov registry entry for NCT07342452 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sofwave is the first listed.
NCT07342452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07342452 about?
NCT07342452 is a clinical study titled "Randomized Trial of Combination Treatment With Sofwave and Sculptra". Evaluation of treatment on the upper arm with Sculptra and Sofwave on the same day versus Sofwave followed by Sculptra 1 month later.
What is the current status of trial NCT07342452?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2026-07. Estimated completion is 2027-04-01.
What interventions are being tested in trial NCT07342452?
The interventions under investigation include: Sofwave (DEVICE), Sculptra (DRUG).
Who is sponsoring clinical trial NCT07342452?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.